Company Quick10K Filing
GT Biopharma
S-1 2020-07-14 Public Filing
10-Q 2020-03-31 Filed 2020-05-15
10-K 2019-12-31 Filed 2020-03-27
10-Q 2019-09-30 Filed 2019-11-14
S-1 2019-09-13 Public Filing
10-Q 2019-06-30 Filed 2019-08-14
S-1 2019-06-21 Public Filing
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-29
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-03-01
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-04-28
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-10
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-14
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2015-01-08
10-Q 2014-06-30 Filed 2015-01-08
10-Q 2014-03-31 Filed 2015-01-08
10-K 2014-03-31 Filed 2015-01-08
10-Q 2013-09-30 Filed 2014-12-17
10-Q 2013-06-30 Filed 2014-12-12
10-Q 2013-03-31 Filed 2014-12-10
10-K 2012-12-31 Filed 2014-11-18
10-Q 2012-09-30 Filed 2012-11-21
10-Q 2012-06-30 Filed 2012-08-20
10-Q 2012-03-31 Filed 2012-05-21
10-Q 2011-09-30 Filed 2011-11-21
10-Q 2011-06-30 Filed 2011-08-22
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-03-31 Filed 2010-05-14
10-K 2009-12-31 Filed 2010-03-30
8-K 2020-07-07 Enter Agreement, Sale of Shares, Exhibits
8-K 2020-06-23
8-K 2020-06-19
8-K 2020-05-29
8-K 2019-09-19
8-K 2019-08-20
8-K 2019-05-22
8-K 2019-04-19
8-K 2019-04-04
8-K 2019-03-20
8-K 2019-03-15
8-K 2019-02-04
8-K 2019-01-07
8-K 2019-01-07
8-K 2018-11-15
8-K 2018-11-01
8-K 2018-10-11
8-K 2018-10-09
8-K 2018-09-24
8-K 2018-09-07
8-K 2018-08-02
8-K 2018-07-02
8-K 2018-05-09
8-K 2018-04-23
8-K 2018-02-14
8-K 2018-01-22
8-K 2018-01-16

GT Biopharma Financials

GTBP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Quotemedia (QMCI) 12 51% 8.6 10% 5 6 9 4 0 1 11
Peak Pharmaceuticals (PKPH) 12 -337.7 -222% 0 0 0 0 -0 -0 12
Paradise (PARF) 12 10% -11.6 -6% 23 2 12 1 -1 -1 9
LifeApps Brands (LFAP) 12 100% -3.1 -5,753% 0 2 0 0 -4 -4 12
Track Group (TRCK) 12 55% 12.6 -6% 48 48 33 18 -3 3 39
Crown Equity (CRWE) 12 0% -29.6 -587% 0 0 0 0 -0 -0 12
Duo World (DUUO) 12 62% -22.1 -52% 1 5 1 0 -1 -1 12
Verde Resources (VRDR) 12 -276% -51.3 -1,494% 0 2 0 -0 -0 -0 12
ADM Tronics Unlimited (ADMT) 11 45% -25.8 -8% 6 2 3 1 -0 -0 10
Nanoflex Power (OPVS) 11 0% -2.6 -1,984% 0 13 0 0 -10 -4 11
Huale Acoustics (HYAS) 11 -446.4 -284% 0 0 0 0 -0 -0 11
GT Biopharma (GTBP) 11 -0.3 -7,713% 0 19 0 0 -37 -36 11
Phoenix Apps (PXPP) 11 -126.2 0 0 0 0 -0 -0 11
Ethos Media Network (EOMN) 11 0% 20.4 309% 0 0 0 0 0 1 11
VerifyMe (VRME) 11 79% -5.5 -142% 1 1 0 0 -2 -2 10
Leafbuyer (LBUY) 11 100% -1.1 -109% 7 3 2 2 -7 -8 8
Sino Agro Food (SIAF) 11 17% 0.9 2% 792 79 105 18 17 17 16
Diego Pellicer (DPWW) 11 7.6 -19% 5 12 0 0 -1 1 11
Acorn Energy (ACFN) 11 65% -18.5 -12% 4 5 4 3 -1 -1 9
Telkonet (TKOI) 11 38% -3.6 -24% 9 5 9 3 -2 -2 7

Balance Sheet ($MM)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302014-03-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash00000000000111000000000313110000
Accounts Receivable00000
Inventory000000000000
PP&E000000000000000000000
Assets00000000000111000000000257254257255272526260
Accounts Payable11111111111100011222222332222222
Long-Term Debt
Liabilities5556756667712305123256220161719182033591314161719
Stockholders' Equity-5-5-5-6-6-5-6-6-6-7-7-11-30-50-23-25-62-20-16-17-19-18-202542522522461311109-18
Income Statement ($MM)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302014-03-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue0000000000000000000000000000
Cost of Revenue0000000000000000000000000000
Gross Profit-00000000000-0-0000000000000000
R&D0-00000000000000100000010361101
SG&A11010000000121324221111266425324
Tax000000000000000000000000000000
Net Income0-1-1-1-102-0-0-0-0-4-2127-2-37262-4-3-2-2-132-6-10113-236-5-3-30
Cash Flow ($MM)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302014-03-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-0-0-0-00-0-0-0-1-1-2-1-1-1-0-1-1-0-1-0-2-2-4-2-3-1-1-1
Cash Investing-00-0000
Cash Financing0000000011201101001050704111